Reviva Pharmaceuticals Holdings (RVPH) Tax Rate (2021 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Tax Rate of 0.1% for Q1 2026, down 125.22% sequentially from 0.42% in Q4 2025, and down 2.0% YoY from 0.11% in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) Tax Rate (2021 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Tax Rate for 6 years, with the latest figure at 0.1% in Q1 2026.
- Quarterly Tax Rate fell 2.0% year-over-year to 0.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (down 183.0% YoY) and the FY2025 annual result came in at 0.01%, up 3801.0% from the prior year.
- Tax Rate eased to 0.1% in Q1 2026 per RVPH's latest filing, from 0.42% in the prior quarter.
- Over five years, Tax Rate peaked at 1.2% in Q4 2023 and troughed at 0.13% in Q2 2025.
- A 5-year average of 0.04% and a median of 0.06% in 2025 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2023 and 2024: Tax Rate jumped 113 bps in 2023, then sank 118 bps in 2024.
- Over 5 years, Tax Rate stood at 0.07% in 2022, then jumped by 1709 bps to 1.2% in 2023, then plunged by 98 bps to 0.02% in 2024, then surged by 1971 bps to 0.42% in 2025, then plunged by 125 bps to 0.1% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.1%, 0.42%, and 0.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Reviva Pharmaceuticals Holdings | 6.47 Mn | 6.47 Mn | - | -0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11% |
| Jun 30, 2026 | -0.11% |
| Jun 30, 2026 | -0.11% |
| Mar 31, 2026 | -0.10% |
| Mar 31, 2026 | -0.10% |
| Mar 31, 2026 | -0.10% |
| Dec 31, 2025 | 0.42% |
| Dec 31, 2025 | 0.42% |
| Dec 31, 2025 | 0.42% |
| Sep 30, 2025 | -0.07% |
| Sep 30, 2025 | -0.07% |
| Sep 30, 2025 | -0.07% |
| Jun 30, 2025 | -0.13% |
| Jun 30, 2025 | -0.13% |
| Jun 30, 2025 | -0.13% |
| Mar 31, 2025 | -0.08% |
| Mar 31, 2025 | -0.08% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | 0.02% |
| Dec 31, 2024 | 0.02% |